Home
Events
Jobs
About
Members
Contact Us
VGXI, Inc. Establishes Pilot mRNA Manufacturing Capabilities
December 6, 2019
by
Website Admin
in
Tweet
Share
Pin it
Previous Story
Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data For LX9211
Next Story
Salarius Pharmaceuticals Receives FDA Fast Track Designation for Lead Drug Candidate, Seclidemstat, in Relapsed or Refractory Ewing Sarcoma
Top